Hepatitis C News Release

October 1, 2001 -- Because of its important clinical implications, the New England Journal of Medicine has released an article about hepatitis C today, a month and a half before the article was due to appear in print in the November 15 issue of the Journal. The essence of the article is that: "Treatment of acute hepatitis C with interferon alfa-2b prevents chronic infection."

Hepatitis C is due to a virus that infects, inflames, and destroys the liver. It is a huge health problem. More than 4 million people in the US and 170 million in the world are currently infected with hepatitis C virus (HCV).

In people infected with HCV, chronic infection often develops and is difficult to eradicate. Chronic hepatitis due to HCV is the most common reason for liver transplantation in the US and Western Europe.

Health Solutions From Our Sponsors